KR20230031411A - Method of manufacturing black maekmundong and liquid preparations enhanced steroidal saponin contents and antioxidant activity by fermentation and nine steam and dry - Google Patents
Method of manufacturing black maekmundong and liquid preparations enhanced steroidal saponin contents and antioxidant activity by fermentation and nine steam and dry Download PDFInfo
- Publication number
- KR20230031411A KR20230031411A KR1020210113605A KR20210113605A KR20230031411A KR 20230031411 A KR20230031411 A KR 20230031411A KR 1020210113605 A KR1020210113605 A KR 1020210113605A KR 20210113605 A KR20210113605 A KR 20210113605A KR 20230031411 A KR20230031411 A KR 20230031411A
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation
- fermented
- black
- liquid
- maekmundong
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 86
- 230000004151 fermentation Effects 0.000 title claims abstract description 85
- 239000007788 liquid Substances 0.000 title claims abstract description 53
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 230000003078 antioxidant effect Effects 0.000 title abstract description 11
- 229930002600 steroidal saponin Natural products 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 26
- 230000032683 aging Effects 0.000 claims abstract description 25
- 238000010025 steaming Methods 0.000 claims abstract description 22
- 238000001035 drying Methods 0.000 claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 229930091371 Fructose Natural products 0.000 claims description 13
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 13
- 229960002737 fructose Drugs 0.000 claims description 13
- 241000332371 Abutilon x hybridum Species 0.000 claims description 12
- 230000005070 ripening Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 235000008504 concentrate Nutrition 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 8
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 8
- 244000298697 Actinidia deliciosa Species 0.000 claims description 8
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 8
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 8
- 241001668545 Pascopyrum Species 0.000 claims description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 244000144730 Amygdalus persica Species 0.000 claims description 7
- 235000014443 Pyrus communis Nutrition 0.000 claims description 7
- 235000020374 simple syrup Nutrition 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 229930182490 saponin Natural products 0.000 abstract description 20
- 150000007949 saponins Chemical class 0.000 abstract description 15
- 230000001965 increasing effect Effects 0.000 abstract description 13
- 239000004480 active ingredient Substances 0.000 abstract description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 12
- 239000012669 liquid formulation Substances 0.000 abstract description 9
- 150000003431 steroids Chemical class 0.000 abstract description 6
- 150000005856 steroid saponins Chemical class 0.000 abstract description 5
- 229930190017 ophiopogonin Natural products 0.000 abstract description 4
- 241001448424 Ophiopogon Species 0.000 abstract 2
- 229930195210 Ophiopogon Natural products 0.000 abstract 2
- 241000221013 Viscum album Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 28
- 241000244206 Nematoda Species 0.000 description 22
- 235000017709 saponins Nutrition 0.000 description 19
- 240000000560 Citrus x paradisi Species 0.000 description 13
- 229920000742 Cotton Polymers 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 239000003642 reactive oxygen metabolite Substances 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 239000003172 expectorant agent Substances 0.000 description 8
- 230000003419 expectorant effect Effects 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 241000220324 Pyrus Species 0.000 description 7
- 102000019197 Superoxide Dismutase Human genes 0.000 description 7
- 108010012715 Superoxide dismutase Proteins 0.000 description 7
- 230000000954 anitussive effect Effects 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000002038 ethyl acetate fraction Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- -1 opiopogonins A Natural products 0.000 description 7
- 230000036542 oxidative stress Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 101100203566 Caenorhabditis elegans sod-3 gene Proteins 0.000 description 6
- 102000016938 Catalase Human genes 0.000 description 6
- 108010053835 Catalase Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 6
- 101100533820 Rattus norvegicus Sod3 gene Proteins 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 229940124584 antitussives Drugs 0.000 description 6
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 5
- 230000035800 maturation Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000244203 Caenorhabditis elegans Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- KQPYUDDGWXQXHS-UHFFFAOYSA-N juglone Chemical compound O=C1C=CC(=O)C2=C1C=CC=C2O KQPYUDDGWXQXHS-UHFFFAOYSA-N 0.000 description 4
- 241000244202 Caenorhabditis Species 0.000 description 3
- 244000018436 Coriandrum sativum Species 0.000 description 3
- 235000002787 Coriandrum sativum Nutrition 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241000219094 Vitaceae Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000021021 grapes Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- APTNOIWSCDBIAS-UHFFFAOYSA-N 5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C(O)C(O)C(CO)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C APTNOIWSCDBIAS-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- VYTBDSUNRJYVHL-UHFFFAOYSA-N beta-Hydrojuglone Natural products O=C1CCC(=O)C2=C1C=CC=C2O VYTBDSUNRJYVHL-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000006993 memory improvement Effects 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 2
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 1
- PXEZTIWVRVSYOK-UHFFFAOYSA-N 2-(3,6-diacetyloxy-2,7-dichloro-9h-xanthen-9-yl)benzoic acid Chemical compound C1=2C=C(Cl)C(OC(=O)C)=CC=2OC2=CC(OC(C)=O)=C(Cl)C=C2C1C1=CC=CC=C1C(O)=O PXEZTIWVRVSYOK-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241000383638 Allium nigrum Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 241000132456 Haplocarpha Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001532026 Liriope muscari Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KGGGRGBDMBZXKF-UHFFFAOYSA-N Virganreagenin G Natural products C1C(O)C(O)C(C)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C KGGGRGBDMBZXKF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- BDCUGHMNUOTFKX-YJGMJMKZSA-N [(2s,3r,4s,5s)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4ar,5r,6ar,6as,6br,8ar,9r,10r,11s,12ar,14bs)-5,11-dihy Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-YJGMJMKZSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- BDCUGHMNUOTFKX-DDRWPPTGSA-N polygalacin D Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-DDRWPPTGSA-N 0.000 description 1
- DJPJACADAIGMKF-CTELNEMLSA-N polygalacin-D Natural products O=C(O[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O[C@@]4(O)[C@H](O)[C@@](O)(CO)CO4)[C@H](O)CO3)[C@H](C)O2)[C@@H](O)[C@@H](O)CO1)[C@@]12[C@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@@](CO)(C)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O)C5)CC4)CC=C3[C@@H]1CC(C)(C)CC2 DJPJACADAIGMKF-CTELNEMLSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 스테로이드계 사포닌의 유효성분이 증가된 흑맥문동의 제조방법 및 이를 포함한 액상제제의 제조방법에 관한 것으로서, 보다 상세하게는 맥문동을 다섯종류의 천연과일 당침 발효숙성액으로 5단계의 발효 및 숙성단계와 9단계의 증숙 및 건조 단계를 통해 스테로이드계 사포닌의 활성성분인 오피오포고닌(Ophiopogonin)의 함량과 항산화 활성을 증대시킨 원형 발효증숙 흑맥문동의 제조방법 및 이를 포함한 액상제제의 제조방법에 관한 것이다. The present invention relates to a method for manufacturing black grapefruit with increased active ingredients of steroid-based saponin and a method for manufacturing a liquid formulation including the same, and more particularly, to a five-step fermentation and aging of black grapefruit with five kinds of natural fruit sugar acupuncture fermentation liquid. Method for producing round-shaped fermented and steamed black grapefruit with increased content and antioxidant activity of Ophiopogonin, an active ingredient of steroid saponin, through steaming and drying steps of
맥문동(麥門冬, Liriope platyphylla)은 백합과(Liliaceae)에 속하는 다년생 상록초본으로 산지의 나무그늘이나 초지에 자생하는 식물로써 한국, 타이완, 일본 등에 분포하고 산지의 나무 그늘에서 자라며 불사초라고도 부른다. Liriope platyphylla is a perennial evergreen herb belonging to the Liliaceae family.
높이는 30~50센티미터 정도이고 뿌리줄기가 짧고 굵으며, 수염뿌리는 가늘고 긴데 어떤 것은 굵어져서 덩이뿌리가 된다. The height is about 30 to 50 cm, the rhizome is short and thick, and the beard root is thin and long, but some become thick and become tuberous roots.
잎은 짙은 녹색으로 뿌리줄기에서 뭉쳐나고 선형으로서 밑부분이 좁아져 잎집을 형성한다. 꽃은 5-6월에 연한 자주색으로 피는데 마디마다 3-5개씩 모여 달려 길이 8~12센티미터의 총상 꽃차례를 이룬다. Leaves are dark green, gathered together at the rhizome, linear, and narrow at the bottom to form a leaf sheath. Flowers bloom in May-June in light purple, and 3-5 flowers are gathered at each node to form raceme inflorescences with a length of 8 to 12 cm.
열매는 장과로서 구형이며 일찍 껍질이 벗겨지는데 흑색의 씨가 노출된다.The fruit is a berry, spherical, and the skin peels off early to expose the black seeds.
맥문동의 덩이뿌리를 말리면 반투명한 담황색이 되는데, 기침과 가래를 멎게하거나 폐장의 기능을 돕고 기력을 돋우는데 효과가 있다고 알려져 있다. When the tuberous root of Macmundong is dried, it becomes translucent light yellow, and it is known to be effective in stopping cough and phlegm, helping the function of the lungs, and boosting energy.
한방에서는 이것을 강장·거담·진해·강심제 등에 사용한다. In oriental medicine, it is used as a tonic, expectorant, antitussive, and cardiac medicine.
맥문동에는 스테로이드계 사포닌인 오피오포고닌 A, B, C, D, 호모이소플라보노이드, 올리고사카라이드 및 폴리사카라이드 등을 함유하고 있어 다양한 기능성이 있는 것으로 알려져 있으며, 최근에는 해열, 진해, 거담작용, 항염증작용, 혈당강하효과, 뇌세포 보호작용, 기억력 증진효과 등이 보고되고 있다.Macmundong is known to have various functionalities as it contains steroidal saponins such as opiopogonins A, B, C, D, homoisoflavonoids, oligosaccharides and polysaccharides. Anti-inflammatory action, blood sugar lowering effect, brain cell protection action, memory enhancement effect, etc. have been reported.
이와 같이 맥문동은 다양한 생리활성을 가지고 있지만 스테로이드계 사포닌과 항산화 물질에 대한 연구는 미미한 실정이다. As such, Maekmundong has various physiological activities, but studies on steroid-based saponins and antioxidants are insignificant.
한편 올레아난계 사포닌을 함유하고 있는 도라지는 플라티코디제닌(platycodigenin)을 아글리콘(aglycone)으로 하는 플라티코딘(platycodin) A, C, D, D2, D3, 플라티코디제닌 산(platycodigenic acid) A1~A5, C, 폴리갈라신(polygalacin) D, D2, 폴리갈라신 산(polygalacic acid), 플라티코디제닌(platycodigenic) 등으로 뿌리의 약 2 %를 차지한다.On the other hand, bellflower containing oleanane saponin contains platycodigenin as an aglycone, platycodins A, C, D, D2, D3, and platycodigenic acid. ) A1~A5, C, polygalacin D, D2, polygalacic acid, and platycodigenic, which account for about 2% of the root.
도라지는 위점막을 자극하고 기관지 분비를 촉진하여 점액분비량이 현저히 증가됨으로써 거담작용을 나타내며, 플라티코딘 D를 척수에 투여하면 통증에 대한 감수성이 현저히 저하됨으로써 진통작용과 함께 항염작용을 나타낸다. Bellflower stimulates the gastric mucosa and promotes bronchial secretion, thereby significantly increasing the amount of mucus secretion, thereby exhibiting an expectorant action.
한방에서는 진해작용, 거담 작용, 진통작용 및 항염작용이 뛰어나 진해·거담약으로 기침·기관지염에 많이 쓰이고 있다. In oriental medicine, it has excellent antitussive, expectorant, analgesic and anti-inflammatory effects, and is widely used for cough and bronchitis as an antitussive and expectorant medicine.
또한 다마란계 사포닌을 함유하고 있는 인삼은 주로 프로토파낙사디올 (Protopanaxadiol)과 프로토파낙사트리올(Protopanaxatriol)로 구성되는데 프로토파낙사디올은 진세노사이드(Ginsenoside) Ra1, Ra2, Rb1, Rb2, Rb3, Rc, Rd 등으로 구성되어 있고, 프로토파낙사트리올(Protopanaxatriol)은 Re, Rf, Rg1, Rg2, Rh1 등으로 구성되어 있다.In addition, ginseng containing damaran saponins is mainly composed of Protopanaxadiol and Protopanaxatriol. It is composed of Rb3, Rc, Rd, etc., and Protopanaxatriol is composed of Re, Rf, Rg1, Rg2, Rh1, etc.
인삼의 약리작용으로는 면역 증강작용으로써 임파구 증식작용이 강하고 인터페론의 생성을 증가시키며, 네츄럴킬러세포(natural killer cell)의 활성을 현저하게 증가시킨다.As for the pharmacological action of ginseng, it has a strong lymphocyte proliferation action as an immune enhancing action, increases the production of interferon, and remarkably increases the activity of natural killer cells.
심혈관계에 대한 작용으로는 심장박동수와 중심정맥압을 낮추고 허혈성심근세포에서 비정상적인 효소활성을 정상화하며, 노화에 따른 심근세포의 퇴행성변화를 줄여준다.As for the action on the cardiovascular system, it lowers heart rate and central venous pressure, normalizes abnormal enzyme activity in ischemic cardiomyocytes, and reduces degenerative changes in cardiomyocytes due to aging.
중추신경에 대한 작용으로는 마음을 안정시키고 구토중추와 호흡중추를 항진시키며, 중추신경억제작용을 나타낸다.As for the action on the central nervous system, it stabilizes the mind, stimulates the vomiting center and respiratory center, and shows a central nervous system suppression effect.
항산화제는 산화적 손상을 늦추거나 방해하며 혹은 제거할 수 있는 능력을 가진 물질로서 인체 내에는 수퍼옥시드디스뮤타아제(superoxide dismutase, SOD), 글루타치온 과산화효소(glutathione peroxidase) 및 카탈라아제(catalase) 등과 같은 항산화 효소들이 존재하지만 이들만으로는 불완전하여 건강을 유지하기 위해서는 외부에서 공급되는 항산화제의 공급이 필요하다. Antioxidants are substances that have the ability to slow down, interfere with, or eliminate oxidative damage. In the human body, there are superoxide dismutase (SOD), glutathione peroxidase, and catalase. The same antioxidant enzymes exist, but these alone are incomplete, so the supply of antioxidants supplied from the outside is necessary to maintain health.
최근에 산화적 스트레스와 노화와의 관계에 대한 관심이 커지면서 항산화제를 노화지연 또는 수명연장을 위해 사용하고자 하는 연구들이 많이 이루지고 있다. 그러나 대표적인 항산화제인 비타민 A, C, E 등이 실제로는 노화지연 또는 수명연장에 대한 효과가 미약하거나 오히려 투여량에 따라서는 악영향을 미치는 연구결과가 발표되는 등 항산화와 노화, 수명의 관계는 논란이 지속되고 있다. 이는 노화와 장수에 관련된 기전은 단순히 항산화의 효과에 의해 좌우되지 않고 내외적인 여러 요소가 작용하기 때문이라고 보고되고 있다.Recently, as interest in the relationship between oxidative stress and aging has increased, many studies have been conducted to use antioxidants for aging delay or life extension. However, the relationship between antioxidants, aging, and longevity is controversial, with studies showing that typical antioxidants such as vitamins A, C, and E actually have little effect on delaying aging or extending lifespan, or have adverse effects depending on the dose. It is continuing. It has been reported that this is because the mechanisms related to aging and longevity are not simply influenced by the effects of antioxidants, but because various internal and external factors work.
본 발명은 다섯종류의 천연과일 발효숙성액을 제 1 발효, 제 2 발효 및 숙성단계를 다른 종류의 천연과일 당침 발효 숙성액으로 반복하고, 증숙 및 건조 단계를 9번 반복하여 맥문동에 함유되어 있는 스테로이드계 사포닌의 함량을 증가시키고, 여기에 올레아난계 사포닌을 함유한 흑도라지와 다마란계 사포닌을 함유한 흑삼을 복합함으로써 사포닌의 효능과 항산화 활성을 현저하게 증대시킨 액상제제를 개발하고자 한다. The present invention repeats the first fermentation, second fermentation, and aging steps of five types of natural fruit fermented fermentation broth with different types of natural fruit fermented fermentation broth, and repeats the steaming and drying steps nine times to obtain It is intended to develop a liquid formulation that significantly increases the efficacy and antioxidant activity of saponins by increasing the content of steroid saponins and combining black bellflower containing oleanane saponins with black ginseng containing damaran saponins.
스테로이드계 사포닌을 함유하고 있는 맥문동의 효능은 해열작용, 진해작용, 거담작용, 항염증작용, 혈당강하효과, 뇌세포 보호작용, 기억력 증진효과 등이 보고되어 있고, 올레아난계 사포닌을 함유하고 있는 도라지의 효능은 진해작용, 거담 작용, 진통작용 및 항염작용이 뛰어나 진해·거담약으로 기침 및 기관지염에 쓰이고 있으며, 다마란계 사포닌을 함유하고 있는 인삼의 효능은 면역증강, 피로회복, 기억력개선, 혈행개선, 항산화효능이 널리 알려져 있다. As for the efficacy of the macmundong containing steroidal saponin, antipyretic action, antitussive action, expectorant action, anti-inflammatory action, blood sugar lowering effect, brain cell protecting action, memory enhancement effect, etc. have been reported. The efficacy of bellflower is excellent in antitussive, expectorant, analgesic and anti-inflammatory effects, and is used for cough and bronchitis as an antitussive and expectorant. It is widely known for its blood circulation improvement and antioxidant effects.
본 발명은 스테로이드계 사포닌의 해열 소염작용과 올레아난계 사포닌의 진해 거담작용에 다마란계 사포닌의 면역증강 및 혈행개선 효능이 복합되어 있는 다양한 사포닌 복합 액상제제를 개발하는 것이다. The present invention is to develop various saponin complex liquid formulations in which the antipyretic and anti-inflammatory action of steroid saponins and the antitussive and expectorant action of oleanane saponins are combined with the immunity enhancing and blood circulation improving effects of damaran saponins.
효율적인 제품개발을 위하여 먼저, 스테로이드계 사포닌을 함유한 맥문동에 다섯 종류의 천연과일 당침 발효 숙성액으로 제 1 발효, 제 2 발효 및 숙성단계를 반복하고, 증숙 및 건조 단계를 9번 반복하여 유효성분인 오피오포고닌(Ophiopogonin)의 함량을 현저하게 증가시킨 원형 발효증숙 흑맥문동의 제조방법과 올레아난계 사포닌을 함유한 흑도라지 및 다마란계 사포닌을 함유한 흑삼추출물을 복합함으로써 사포닌의 효능과 함께 항산화 활성을 증대시킨 발효증숙 흑맥문동 복합 액상제제의 제조방법을 제공하는 것이다.For efficient product development, first, the 1st fermentation, 2nd fermentation and maturation steps were repeated with five kinds of natural fruit fermented liquids in Maekmundong containing steroid-based saponin, and the steaming and drying steps were repeated 9 times to obtain active ingredients. By combining the manufacturing method of fermented and steamed black maltose with a significantly increased content of phosphorus ophiopogonin, black bellflower containing oleanane saponin, and black ginseng extract containing damaran saponin, the effect of saponin is It is to provide a method for producing a fermented and steamed black maltune complex liquid formulation with increased antioxidant activity.
본 발명은 (1) 맥문동을 세척탱크에 넣고 온수로 세척한 후 열풍건조기에 넣어 건조시키는 전처리 단계 ; The present invention includes (1) a pretreatment step of putting wheatgrass in a washing tank, washing it with hot water, and drying it in a hot air dryer;
(2) 전처리된 상기 맥문동에 천연과일 당침발효 숙성액을 가하여 발효시키는 1차 발효 단계 ; (2) a first fermentation step of fermenting by adding a natural fruit sweetener fermented liquid to the pre-treated Maekmundong;
(3) 상기 1차 발효 단계를 거친 상기 맥문동에 다시 상기 천연과일 당침발효 숙성액을 분사하여 발효시키는 2차 발효 단계; (3) a secondary fermentation step of fermenting by injecting the natural fruit sugar syrup fermentation liquid back into the macmundong that has gone through the primary fermentation step;
(4) 상기 2차 발효과정을 거친 맥문동을 일정 온도에서 숙성시키는 단계 ; (4) ripening the maekmundong that has undergone the secondary fermentation process at a constant temperature;
(5) 상기 숙성단계를 거친 맥문동을 증숙기에 넣고 스팀을 통과시켜 증숙시키는 단계 ; (5) Putting the ripening step into a steamer and steaming it through steam;
(6) 상기 증숙단계를 거친 맥문동을 건조시키는 단계 ; 를 포함하는 원형 발효 증포 맥문동의 제조방법에 관한 것이다. (6) drying the maekmundong that has undergone the steaming step; It relates to a method for producing circular fermented steamed wheatgrass comprising a.
또한, 본 발명은 In addition, the present invention
원형 발효증포 흑맥문동, 흑도라지 농축액과 흑삼 농축액에 물을 가하여 가열 추출하는 단계 ; Heating and extracting water by adding water to the circular fermented and steamed black coriander, black bellflower concentrate, and black ginseng concentrate;
상기 추출액을 여과하고 여액을 감압농축기에 넣고 농축시키는 단계를 포함하는 발효증포 흑맥문동 복합 액상제제의 제조방법에 관한 것이다. It relates to a method for producing a fermentation-vaporised black maltune complex liquid preparation comprising the step of filtering the extract and concentrating the filtrate in a vacuum concentrator.
본 발명은 건조 맥문동과 발효증포 흑맥문동에 함유된 스테로이드계 사포닌 중 오피오포고닌의 함량을 측정 비교하고, The present invention measures and compares the content of opioponin among steroidal saponins contained in dried and fermented fermented black grapefruit,
건조 맥문동과 발효증포 흑맥문동의 디피피에이치 라디컬(DPPH radical) 소거능을 측정 비교하고, Measure and compare the DPPH radical scavenging ability of dried and fermented black malts,
발효증포 흑맥문동을 수종 유기용매로 추출한 후 분획물 중의 디피피에이치 라디컬(DPPH radical) 소거능을 측정 비교하고, After extracting fermented vaporized black maltose with several organic solvents, the DPPH radical scavenging ability in the fractions was measured and compared,
예쁜꼬마선충(Caenorhabditis elegans)을 이용하여 발효증포 흑맥문동의 항산화 효소(SOD, Catalase) 활성을 측정 비교하고,Using Caenorhabditis elegans , the antioxidant enzyme (SOD, Catalase) activity of fermented and steamed black grapes was measured and compared,
예쁜꼬마선충을 이용하여 발효증포 흑맥문동의 세포 내 활성산소종(ROS) 축적 억제 활성을 측정 비교하고, Using Caenorhabditis elegans to measure and compare the inhibitory activity of intracellular reactive oxygen species (ROS) accumulation of fermented and distilled black grapes,
예쁜 꼬마선충을 이용하여 발효증포 흑맥문동의 산화적 스트레스 저항성을 측정 비교하고, Measurement and comparison of oxidative stress resistance of fermented steamed black grapefruits using Caenorhabditis nematodes,
예쁜 꼬마선충을 이용하여 발효증포 흑맥문동의 형질전환 선충 내 SOD-3::GFP 형광 발현 강도를 측정 비교하였다. The intensity of SOD-3::GFP fluorescence expression in the transgenic nematodes of fermented nematodes was measured and compared using Caenorhabditis elegans.
본 발명은 맥문동에 무화과, 배, 키위, 매실, 개복숭아 등 다섯종류의 천연과일 당침 발효숙성액을 사용하여 5차례에 걸친 1차 발효, 2차발효 및 숙성단계를 거치고, 이어서 9단계에 걸친 증숙 및 건조단계를 통해 스테로이드계 사포닌의 활성성분인 오피오포고닌(Ophiopogonin)의 함량을 현저하게 증가시킨 원형 발효증숙 흑맥문동을 제조할 수 있다. The present invention goes through 5 stages of primary fermentation, secondary fermentation and maturation using five kinds of natural fruits such as fig, pear, kiwi, plum, and peach, etc. Through the steaming and drying steps, it is possible to produce a circular fermented and steamed black maltongdong with significantly increased content of Ophiopogonin, an active ingredient of steroid saponin.
또한, 본 발명은 원형 발효증숙 흑맥문동, 올레아난계 사포닌을 함유한 흑도라지 농축액 및 다마란계 사포닌을 함유한 흑삼 농축액으로부터 복합액상 제제를 추출함으로서 사포닌의 복합 효능을 현저하게 증대시킨 발효숙성 구증구포 흑맥문동 복합 액상제제의 제조방법을 제공할 수 있다. In addition, the present invention extracts a complex liquid preparation from the original fermented and steamed black coriander, black bellflower concentrate containing oleanane saponin, and black ginseng concentrate containing damaran saponin, thereby significantly increasing the complex efficacy of saponins. It is possible to provide a method for preparing a complex liquid formulation of gupo black malaria.
도 1은 본 발명의 발효숙성 구증구포 흑맥문동의 제조방법을 나타낸 것이다.
도 2는 건조 맥문동의 스테로이드계 사포닌 오피오포고닌의 피크를 보여준다.
도 3은 발효증포 흑맥문동의 스테로이드계 사포닌 오피오포고닌의 피크를 보여주는 것이다.
도 4는 건조 맥문동 및 발효증포 흑맥문동의 디피피에이치 라디컬(DPPH radical) 소거능에 미치는 영향을 실험한 결과이다.
도 5는 발효증포 흑맥문동의 수종 유기용매 추출 분획물 중 디피피에이치 라디컬(DPPH radical) 소거능에 미치는 영향을 실험한 결과이다.
도 6은 발효증포 흑맥문동의 예쁜꼬마선충 내 항산화 효소인 SOD의 활성 증가에 미치는 영향을 실험한 결과이다.
도 7은 발효증포 흑맥문동의 예쁜꼬마선충 내의 항산화효소인 catalase의 활성 증가를 확인한 실험 결과이다.
도 8은 발효증포 흑맥문동의 예쁜꼬마선충 세포 내 ROS의 축적에 미치는 영향을 실험한 결과이다.
도 9는 발효증포 흑맥문동의 예쁜꼬마선충의 산화적 스트레스(oxidative stress) 저항성에 미치는 영향을 실험한 결과이다.
도 10은 발효증포 흑맥문동 물추출물을 형질 전환된 선충으로 SOD-3::GFP를 포함한 CF1553을 시료를 농도별로 제조된 배지에 넣어 배양한 후 형광의 발현 강도를 관찰한 결과이다.
도 11, 도 12는 발효숙성 구증구포 흑맥문동의 제조 및 액상 복합제제의 제조공정이다.1 shows a method for producing fermentation-aged gujeunggupo black maltmundong of the present invention.
Figure 2 shows the peak of the steroid-based saponin opiopogonin of dried rhubarb.
Figure 3 shows the peak of the steroid-based saponin opiopogonin of fermented and steamed black malaria.
4 shows the results of experiments on the effect of dried and fermented black malts on DPPH radical scavenging ability.
Figure 5 is the result of the experiment on the effect on the DPPH radical scavenging ability of several organic solvent-extracted fractions of fermented and evaporated black malt.
Figure 6 is the result of the experiment on the effect of fermented steamed black grapefruit on the increase in the activity of SOD, an antioxidant enzyme in Caenorhabditis elegans.
Figure 7 is an experimental result confirming the increase in the activity of catalase, an antioxidant enzyme in Caenorhabditis nematodes of fermented and evaporated black grapes.
8 is an experimental result of the effect on the accumulation of ROS in C.
Figure 9 is the result of experiments on the effect of fermented steamed black grapefruit on oxidative stress resistance of Caenorhabditis nematodes.
10 is a result of observing the expression intensity of fluorescence after culturing a sample of CF1553 including SOD-3::GFP as a nematode transformed with fermented and evaporated black vein extract in a culture medium prepared for each concentration.
11 and 12 are the manufacturing process of fermentation-aged Gujeung Gupo Black Maltmundong and the manufacturing process of the liquid composite preparation.
이하에서, 본 발명의 바람직한 실시 과정을 도면을 들어 설명한다. 그러나 본 발명의 범위는 하기 실시 과정에 대한 설명 또는 도면에 제한되지 아니한다. 즉, 본 명세서에서 사용한 용어는 단지 특정한 실시 예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 또한, 본 명세서에서 기술되는 "포함 한다" 또는 "가지다" 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다. Hereinafter, a preferred implementation process of the present invention will be described with reference to the drawings. However, the scope of the present invention is not limited to the description or drawing of the following implementation process. That is, terms used in this specification are only used to describe specific embodiments, and are not intended to limit the present invention. Singular expressions include plural expressions unless the context clearly dictates otherwise. In addition, terms such as "include" or "having" described in this specification are intended to designate that there is a feature, number, step, operation, component, part, or combination thereof described in the specification, but one or the other It should be understood that the above does not preclude the possibility of the presence or addition of other features, numbers, steps, operations, components, parts, or combinations thereof.
도 1은 본 발명의 원형 발효증포 흑맥문동의 제조방법을 나타낸 것이다. 1 shows a method for producing circular fermented steamed black maltose of the present invention.
도 1을 참고하면, 본 발명의 흑맥문동 제조방법은 전처리 단계, 1차 발효 단계, 2차 발효 단계, 숙성단계, 증숙 단계 및 건조단계를 포함한다. Referring to FIG. 1 , the method for manufacturing black malt bean sprouts of the present invention includes a pretreatment step, a primary fermentation step, a secondary fermentation step, a maturation step, a steaming step, and a drying step.
본 발명의 원형 발효증포 흑맥문동 제조방법은 다섯가지 종류의 천연과일 발효숙성액의 1차 발효, 2차 발효 및 숙성단계를 각각 4회 이상 6회 정도 반복할 수 있고 바람직하게는 5회 반복할 수 있다. The method for manufacturing circular fermented steamed black maltongdong of the present invention is five kinds of natural fruit fermented ripening liquids. The first fermentation, the second fermentation, and the aging step may be repeated 4 or more 6 times, respectively, and preferably 5 times.
이어서 증숙 및 건조단계는 8회 이상 10회 정도 반복할 수 있고 바람직하게는 9회 반복할 수 있다. Subsequently, the steaming and drying steps may be repeated 8 or more 10 times, preferably 9 times.
상기 (1) 전처리 단계는 맥문동을 세척기에 넣어 온수로 세척한 후 열풍건조기에 넣고 건조시키는 단계이다. The (1) pretreatment step is a step of putting the wheatgrass in a washing machine, washing it with hot water, and then putting it in a hot air dryer and drying it.
예를 들면, 상기 (1) 전처리 단계는 맥문동 뿌리를 세척기에 넣고 40~60℃의 온수로 3회 세척한 후, 열풍건조기로 옮겨 50~70℃에서 4~6시간 동안 건조시키는 단계, 냉풍건조기에 넣은 후 10~20℃에서 12~24시간 동안 냉풍으로 건조시키는 단계를 포함할 수 있다. For example, in the (1) pretreatment step, after putting the root of the rhubarb in a washing machine and washing it three times with hot water at 40 to 60 ° C, transferring it to a hot air dryer and drying it at 50 to 70 ° C for 4 to 6 hours, a cold air dryer It may include a step of drying with cold air at 10 to 20 ° C. for 12 to 24 hours after putting in.
상기 (2) 1차 발효단계는 전처리된 상기 맥문동에 천연과일 당침발효 숙성액을 가하여 발효시키는 단계이다. The (2) primary fermentation step is a step of fermenting by adding a natural fruit sugar syrup fermentation liquid to the pretreated Maekmundong.
상기 천연과일 당침발효 숙성액은 무화과 열매, 배, 키위, 매실 및 개복숭아 중 어느 하나의 과일에 설탕을 가한 후 발효시켜 제조된 과일 효소액이다. The natural fruit sugar syrup fermentation liquid is a fruit enzyme liquid prepared by fermenting after adding sugar to any one fruit of fig fruit, pear, kiwi, plum, and peach.
본 발명은 상기 무화과 열매, 배, 키위, 매실 및 개복숭아 중 어느 하나로 제조된 천연과일 당침 발효 숙성액을 사용할 수 있으며, 바람직하게는 3개 이상의 천연과일 당침 발효 숙성액, 바람직하게는 4개 이상, 보다 바람직하게는 5개의 천연과일 발효숙성액을 모두 사용할 수 있다. In the present invention, a natural fruit fermented fermented liquid made from any one of the fig fruit, pear, kiwi, plum, and peach can be used, preferably three or more natural fruit fermented liquids, preferably four or more. , More preferably, all five natural fruit fermented liquids can be used.
예를 들면, 상기 무화과 발효숙성액은 무화과 8~12kg에 정제설탕 10~14kg을 가하여 균등하게 혼합한 다음, 전통옹기에 넣고 밀봉한 후 직사광선이 닿지 않고 서늘하고 통풍이 원활한 장소에서 3개월 이상 발효시킨 후, 무명으로 여과하고 여과액을 취하여 저장탱크 내에서 20~25℃에서 3개월 이상 숙성시킨 후 다시 무명으로 여과하여 유리용기에 보관한다. For example, the fermented fig fermented liquid is mixed evenly by adding 10 to 14 kg of refined sugar to 8 to 12 kg of figs, and then placed in a traditional pottery, sealed, and exposed to direct sunlight. Fermented for more than 3 months in a cool and well-ventilated place After that, filter through cotton, take the filtrate, mature it in a storage tank at 20~25℃ for more than 3 months, filter it through cotton again, and store it in a glass container.
예를 들면, 상기 배 발효숙성액은 배 8~12kg에 황설탕 10~14kg을 가하여 균등하게 혼합한 다음, 전통옹기에 넣고 밀봉한 후 직사광선이 닿지 않고 서늘하고 통풍이 원활한 장소에서 3개월 이상 발효시킨 후, 무명으로 여과하고 여과액을 취하여 저장탱크 내에서 20~25℃에서 3개월 이상 숙성시킨 후 다시 무명으로 여과하여 유리용기에 보관한다. For example, the pear fermentation ripening liquid is mixed evenly by adding 10 to 14 kg of brown sugar to 8 to 12 kg of pears, and then placed in a traditional pottery, sealed, and exposed to direct sunlight. Fermented for more than 3 months in a cool and well-ventilated place After that, filter through cotton, take the filtrate, mature it in a storage tank at 20~25℃ for more than 3 months, filter it through cotton again, and store it in a glass container.
예를 들면, 상기 키위 발효숙성액은 키위 8~12kg에 정제설탕 10~14kg을 가하여 균등하게 혼합한 다음, 전통옹기에 넣고 밀봉한 후 직사광선이 닿지 않고 서늘하고 통풍이 원활한 장소에서 3개월 이상 발효시킨 후, 무명으로 여과하고 여과액을 취하여 저장탱크 내에서 20~25℃에서 3개월 이상 숙성시킨 후 다시 무명으로 여과하여 유리용기에 보관한다. For example, the kiwi fermented liquid is mixed evenly by adding 10 to 14 kg of refined sugar to 8 to 12 kg of kiwi, and then placed in a traditional pottery, sealed, and exposed to direct sunlight. Fermented for more than 3 months in a cool and well-ventilated place After that, filter through cotton, take the filtrate, mature it in a storage tank at 20~25℃ for more than 3 months, filter it through cotton again, and store it in a glass container.
예를 들면, 상기 매실 발효숙성액은 매실 8~12kg에 황설탕 10~14kg을 가하여 균등하게 혼합한 다음, 전통옹기에 넣고 밀봉한 후 직사광선이 닿지 않고 서늘하고 통풍이 원활한 장소에서 3개월 이상 발효시킨 후, 무명으로 여과하고 여과액을 취하여 저장탱크 내에서 20~25℃에서 3개월 이상 숙성시킨 후 다시 무명으로 여과하여 유리용기에 보관한다. For example, the plum fermentation broth is mixed evenly by adding 10 to 14 kg of brown sugar to 8 to 12 kg of plums, and then sealed in a traditional pottery, and then exposed to direct sunlight. Fermented for more than 3 months in a cool and well-ventilated place After that, filter through cotton, take the filtrate, mature it in a storage tank at 20~25℃ for more than 3 months, filter it through cotton again, and store it in a glass container.
예를 들면, 상기 개복숭아 발효숙성액은 개복숭아 8~12kg에 정제설탕 10~14kg을 가하여 균등하게 혼합한 다음, 전통옹기에 넣고 밀봉한 후 직사광선이 닿지 않고 서늘하고 통풍이 원활한 장소에서 3개월 이상 발효시킨 후, 무명으로 여과하고 여과액을 취하여 저장탱크 내에서 20~25℃에서 3개월 이상 숙성시킨 후 다시 무명으로 여과하여 유리용기에 보관한다. For example, the peach fermented ripening liquid is mixed evenly by adding 10 to 14 kg of refined sugar to 8 to 12 kg of dog peaches, and then placed in a traditional earthenware pot and sealed, and then stored in a cool and well-ventilated place without direct sunlight for 3 months. After over-fermentation, filter through cotton, take the filtrate, mature in a storage tank at 20-25 ° C for more than 3 months, filter again through cotton and store in a glass container.
상기 (2) 1차 발효 단계는 전처리된 상기 맥문동에 천연과일 당침발효 숙성액을 가하여 발효시키는 단계이다. The (2) primary fermentation step is a step of fermenting by adding a natural fruit sugar syrup fermentation broth to the pretreated walnut.
상기 (3) 2 차 발효단계는 상기 1차 발효 단계를 거친 상기 맥문동에 다시 상기 천연과일 당침발효 숙성액을 분사하여 발효시키는 단계이다. The (3) secondary fermentation step is a step of injecting and fermenting the fermented liquid from the natural fruit sugar needles again to the macmundong that has passed through the primary fermentation step.
상기 (4) 숙성단계는 상기 2차 발효과정을 거친 맥문동을 일정 온도에서 숙성시키는 단계이다. The (4) aging step is a step of aging the maekmundong that has undergone the secondary fermentation process at a constant temperature.
본 발명은 앞에서 제조된 천연과일 당침발효 숙성액을 사용하여 (2) 1차 발효 단계, (3) 2차 발효 및 (4) 숙성단계를 거칠수 있다. In the present invention, (2) primary fermentation, (3) secondary fermentation, and (4) aging may be performed using the prepared natural fruit syrup fermentation broth.
좀 더 구체적으로, 상기 (2) 1차 발효 단계 내지 (4) 숙성단계는 More specifically, the (2) primary fermentation step to (4) aging step
(a) 상기 천연과일 당침발효 숙성액 중 어느 하나를 상기 맥문동에 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하는 단계, (a) adding or spraying any one of the natural fruit sugar needle fermented liquids to the maltberry to perform the (2) primary fermentation step, (3) secondary fermentation step, and (4) aging step;
(b) 상기 천연과일 당침발효 숙성액 중 나머지 어느 하나를 상기 (a) 단계를 거친 맥문동에 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하는 단계, 및 (b) Adding or spraying the remaining one of the natural fruit sugar needle fermentation liquid to the wheatgrass that has gone through the step (a), the (2) primary fermentation step, (3) secondary fermentation step, and (4) aging step The step of proceeding, and
상기 천연과일 당침발효 숙성액 중 마지막 숙성액까지 순차적으로 앞의 (2) 1차 발효 단계 내지 (4) 숙성단계를 거친 맥문동에 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하는 단계를 포함할 수 있다. Among the natural fruit sugar needle fermented liquids, up to the last matured liquid is sequentially added to or sprayed to Maekmundong that has undergone the previous (2) 1st fermentation step to (4) ripening step, so that the above (2) 1st fermentation step, (3) 2 It may include a step of proceeding with a tea fermentation step and (4) aging step.
앞에서 제조된 5개의 천연과일 발효숙성액을 모두 사용하는 경우, 예를 들면, 무화과 발효숙성액을 사용하여 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하고(1회째), 이어서, 무화과 발효숙성액으로 발효 및 숙성된 상기 맥문동에 배 발효숙성액을 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행한다(2회째). In the case of using all the five natural fruit fermented liquids prepared above, for example, using fig fermented liquid, (2) 1st fermentation step, (3) 2nd fermentation step, and (4) ripening step are performed. (1st time), and then, by adding or spraying pear fermented liquid to the fermented and aged fig fermented liquid, the (2) primary fermentation step, (3) secondary fermentation step and (4) aging Proceed through the steps (2nd time).
또한, 2회째 발효 및 숙성된 맥문동에 키위 발효숙성액을 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하고(3회째), 계속해서, 3회째 발효 및 숙성된 맥문동에 매실 발효숙성액을 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하고(4회째), 4회째 발효 및 숙성된 맥문동에 개복숭아 발효숙성액을 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행한다(5회째), In addition, by adding or spraying kiwi fermented liquid to the fermented and aged macmundong for the second time, the (2) first fermentation step, (3) second fermentation step, and (4) aging step are performed (third time), and So, by adding or spraying plum fermented liquid to the fermented and aged Maekmundong for the 3rd time, the (2) 1st fermentation step, (3) 2nd fermentation step and (4) aging step are performed (4th time), 4 The (2) 1st fermentation step, (3) 2nd fermentation step and (4) aging step are performed by adding or spraying dog peach fermented liquid to the fermented and aged Maekmundong (5th time),
상기 1차 발효단계는 무화과 발효숙성액, 배 발효숙성액, 키위 발효숙성액, 매실 발효숙성액 및 개복숭아 발효숙성액을 순차적으로 맥문동에 침지 및 침투시킨 후 일정 온도에서 발효시키는 단계이다. The first fermentation step is a step of fermenting at a constant temperature after immersing and infiltrating fermented fig fermented liquid, pear fermented matured liquid, kiwi fermented matured liquid, plum fermented matured liquid and dog peach fermented matured liquid in sequence.
예를 들면, 상기 1차 발효 단계는 전처리된 맥문동 10kg을 5개의 트레이에 펼쳐놓고 천연과일 발효숙성액(예를 들면, 무화과 발효숙성액)을 각 트레이마다 2L씩 가하여 35~45℃에서 20~24시간 동안 (숙성액을 침지 및 침투시켜) 발효할 수 있다. For example, in the first fermentation step, 10 kg of the pre-treated Mammundong is spread out on 5 trays, and 2L of a natural fruit fermented liquid (eg, fig fermented liquid) is added to each tray, and the temperature is 20 ~ 35 ~ 45 ℃. It can be fermented for 24 hours (by soaking and infiltrating the aging liquid).
또한, 2차 발효는 1차 발효가 끝난 맥문동에 발효숙성액(무화과 발효숙성액) 1L씩 분사하여 35~45℃에서 20~24시간동안 발효한다. In addition, for the secondary fermentation, 1L of the fermented fermentation liquid (fig fermentation liquid) is sprayed on Maekmundong after the primary fermentation, and fermented at 35~45℃ for 20~24 hours.
싱기 숙성 단계는 상기 1차 및 2차 발효과정을 거친 맥문동을 일정 온도(예를 들면, 15~25℃)에서 48시간 동안 보관하는 단계이다. Singgi ripening step is a step of storing the first and second fermentation processes at a certain temperature (eg, 15 ~ 25 ℃) for 48 hours.
상기 증숙단계는 상기 숙성단계를 거친 맥문동을 증숙기에 넣고 스팀을 통과시켜 증숙시키는 단계이다. The steaming step is a step of steaming the maekmundong that has passed through the aging step by putting it in a steamer and passing steam therethrough.
상기 1차 발효, 2차 발효 및 숙성단계를 거친 맥문동을 가압스팀 통과장치에 넣고 100~110℃의 스팀으로 1~2시간 동안 증숙시키는 단계로써, 상기 온도 범위에서 통과하는 스팀은 12~22p.s.i이고, 바람직하게는 14.65 p.s.i(100℃)~20.76 p.s.i(110℃)의 압력이 필요하다. The first fermentation, the second fermentation, and the maturation step are put into a pressurized steam passage device and steamed for 1 to 2 hours with steam at 100 to 110 ° C., the steam passing in the temperature range is 12 to 22p. s.i, and preferably a pressure of 14.65 p.s.i (100° C.) to 20.76 p.s.i (110° C.) is required.
상기 증숙단계에서 상기 온도 범위보다 낮으면 맥문동의 증숙이 불가능하고 상기 온도보다 높으면 맥문동의 유효성분이 분해될 수 있다. In the steaming step, if the temperature is lower than the temperature range, the steaming of the brown rice is impossible, and if the temperature is higher than the temperature, the active ingredient of the brown rice may be decomposed.
상기 건조단계는 상기 증숙단계를 거친 맥문동을 서서히 건조시키는 단계이다 The drying step is a step of gradually drying the wheat moondong that has gone through the steaming step.
상기 건조단계는 상기 증숙단계를 거친 맥문동을 열풍건조기에 넣고 60~80℃에서 18~24시간 동안 열풍을 통과시켜 1차 건조한 후 10~20℃에서 6~8시간동안 냉풍을 통과하여 2차 건조한다. In the drying step, the steamed wheatgrass is put in a hot air dryer and dried first by passing hot air at 60 to 80 ° C for 18 to 24 hours, and then secondarily dried by passing cold air at 10 to 20 ° C for 6 to 8 hours. do.
본 발명은 상기 증숙단계와 건조단계를 9회 반복하여 구증구포시킴으로써 흑맥문동의 원형을 그대로 유지시킬 수 있다.
The present invention can maintain the original form of black maltongdong as it is by repeating the steaming step and the drying
본 발명과 달리, 증숙시킨 맥문동을 115℃ 이상의 고온으로 빠르게 건조시킬 경우 흑맥문동의 원형이 유지되지 못하고 모양이 뒤틀릴 뿐만 아니라 유효성분이 분해될 수 있다. Unlike the present invention, when the steamed black grapefruit is quickly dried at a high temperature of 115 ° C. or higher, the original shape of the black grapefruit is not maintained, the shape is distorted, and the active ingredient may be decomposed.
본 발명은 1차 발효, 2차 발효 및 숙성단계를 5회 반복하고, 증숙 및 건조단계는 9회 반복시킬 수 있다. In the present invention, the primary fermentation, secondary fermentation and aging steps may be repeated 5 times, and the steaming and drying steps may be repeated 9 times.
본 발명은 5회의 차 발효, 2차 발효 및 숙성단계를 거친 후, 9회 반복된 증숙 및 건조단계를 거치면서 유효성분의 함량이 가속적으로 높아지게 되며 9회 반복할 경우 최대의 유효성분 효율을 얻을 수 있다. In the present invention, after 5 times of primary fermentation, 2nd fermentation and maturation, the content of active ingredients increases rapidly through repeated 9 times of steaming and drying, and when repeated 9 times, the maximum efficiency of active ingredients is obtained. You can get it.
10회 이상 반복할 경우에는 유효성분의 함량이 더 이상 늘어나지 않고 오히려 분해되는 현상을 발견할 수 있다. When repeated more than 10 times, the content of the active ingredient no longer increases, but rather decomposition can be found.
본 발명에서 발효증포 흑맥문동 복합 액상제제의 제조방법은 먼저 생약 추출장치에 원형 발효증포 흑맥문동과 구증구포 흑도라지 및 구증구포 흑삼을 넣고 정제수를 가하여 가열추출하는 단계, 상기 추출액을 여과하고 여액을 감압농축기에 넣고 농축시키는 단계를 포함한다. In the present invention, the method for producing a fermented and evaporated black maltune complex liquid formulation is firstly, the steps of putting the circular fermented steamed black maltongdong, gujeunggupo black bellflower, and gujeunggupo black ginseng into a herbal medicine extraction device, adding purified water to heat extraction, filtering the extract, and obtaining a filtrate It includes the step of putting in a vacuum concentrator and concentrating.
상기 원형 발효증포 흑맥문동, 구증구포 흑도라지 및 구증구포 흑삼의 중량비는 1 : 1~2 ; 0.5~1일 수 있다. The weight ratio of the prototype fermented and steamed black maltongdong, gujeunggupo black bellflower, and gujeunggupo black ginseng is 1: 1 to 2; It may be 0.5 to 1.
예를 들면, 원형 발효증포 흑맥문동 8~12kg, 구증구포 흑도라지 12~18kg, 구증구포 흑삼 6~8kg을 추출용기에 넣고 90~100℃에서 4~6시간 동안 가열 추출한 후 무명으로 여과할 수 있다. For example, 8-12kg of fermented, fermented black malt, 12-18kg of Gujeunggupo black bellflower, and 6-8kg of Gujeunggupo black ginseng are put into an extraction container, heat-extracted at 90-100°C for 4-6 hours, and then filtered through cotton. there is.
바람직하게는 원형 발효증포 흑맥문동은 10kg, 구증구포 흑도라지 15kg, 구증구포 흑삼 7kg을 추출용기에 넣고 가열추출한 후 무명으로 여과한다. Preferably, 10 kg of round fermented steamed black maltongdong, 15 kg of Gujeunggupo black bellflower, and 7kg of Gujeunggupo black ginseng are put into an extraction container, heated and extracted, and filtered through cotton.
여액을 취하여 감압농축기에 넣고 60~80℃에서 4~6시간동안 감압농축시켜 발효증포 흑맥문동 복합농축액을 얻을 수 있다(40~60brix). The filtrate is taken and put in a vacuum concentrator and concentrated under reduced pressure at 60 to 80 ° C. for 4 to 6 hours to obtain a fermented vaporized black malt brown complex concentrate (40 to 60 brix).
발효증포 흑맥문동 복합농축액에 프락토올리고당, 흑마늘농축액을 혼합한 후 폴리에틸렌 액상스틱에 각각 15g씩 충전한 다음 밀봉하여 액상제제를 제조한다. After mixing fructooligosaccharide and black garlic concentrate with the fermented and evaporated black maltberry complex concentrate, 15g of each is filled into a polyethylene liquid stick and sealed to prepare a liquid formulation.
실험예 1. 맥문동 분석Experimental Example 1. Mcmundong analysis
1) 시료의 전처리 과정 1) Sample pretreatment process
발효증포 흑맥문동을 분쇄하고 분말 1g을 취하여 15mL 시험관에 넣은 후 메탄올(99.99%) 10mL를 첨가하고 소니케이터에 넣은 다음 10분 동안 초음파를 통과시킨다. Crush the fermented and steamed black grapefruit, take 1g of the powder, put it in a 15mL test tube, add 10mL of methanol (99.99%), put it in a sonicator, and pass ultrasonic waves for 10 minutes.
초음파를 통과시킨 시료 5mL를 원심분리관에 취하고 13,000rpm으로 10분 동안 원심분리시킨 후 상등액 1mL를 취하여 발효증포 시료액으로 하였다. After passing ultrasonic waves, 5mL of the sample was taken in a centrifuge tube, centrifuged at 13,000 rpm for 10 minutes, and 1mL of the supernatant was taken to prepare a fermentation sample solution.
별도로 발효증포를 거치지 않은 건맥문동(비교예 1)을 동일하게 조작하여 대조액으로 하였다. A control solution was obtained by operating the same method as the conjunctivitis (Comparative Example 1), which had not been separately fermented and thickened.
2) 분석장치 2) Analyzer
기기명 : 매스 질량 분석장치(MS QQQ Mass Spectrometer model 6410B, Agilent Technologies Co., USA)Device name: Mass spectrometer (MS QQQ Mass Spectrometer model 6410B, Agilent Technologies Co., USA)
칼럼 : Phenomenex Kinetex 2.6um C8 100A 50x2.1mmColumn: Phenomenex Kinetex 2.6um C8 100A 50x2.1mm
3) 분석조건3) Analysis conditions
이동용매 A : 0.1% 개미산(증류수) Mobile solvent A: 0.1% formic acid (distilled water)
이동용매 B : 0.1% 개미산(아세토니트릴)Moving solvent B: 0.1% formic acid (acetonitrile)
유지시간 : 20분Maintenance time: 20 minutes
4) 분석결과4) Analysis result
건맥문동을 발효증포하여 얻은 시료를 분쇄하고 분말 1g을 취하여 메탄올 10mL에 가하고 초음파를 통과시킨 후 원심분리 시키고 상등액 1mL를 발효증포 흑맥문동 시료액으로 하였으며, 그중 10㎕를 매스 질량 분석장치(MS QQQ Mass Spectrometer)에 주입한 다음 A용매(0.1% 개미산(증류수))와 B용매(0.1% 개미산(아세토니트릴))를 적당한 비율로 20분 동안 프로그래밍하여 나타난 피크의 면적을 비교하여 발효증포 전후의 함량을 비교하였다. A sample obtained by fermenting and distillation of dry grapefruit was pulverized, and 1 g of powder was added to 10 mL of methanol, passed through ultrasonic waves, and centrifuged. Mass Spectrometer), then A solvent (0.1% formic acid (distilled water)) and B solvent (0.1% formic acid (acetonitrile)) were programmed at an appropriate ratio for 20 minutes to compare the areas of the peaks that appeared before and after fermentation. was compared.
표 1은 실시예(발효증포흑맥문동), 비교예(일반 맥문동)의 활성성분인 오피오포고닌 A, B, C, D의 성분면적 및 함량비이다. Table 1 shows the component areas and content ratios of opiopogonins A, B, C, and D, which are the active ingredients of Examples (fermented steamed black coriander) and Comparative Example (general corticosteroids).
성분sample
ingredient
표1을 참조하면 건조 맥문동의 오피오포고닌 성분 중 A, B, C는 검출되지 않았고 오피오포고닌 D는 19.07㎍/g으로 나타난 반면, 발효증포 흑맥문동에서는 오피오포고닌 B가 4.78㎍/g으로 미량 검출되었으며 오피오포고닌 D는 78.41㎍/g으로 나타나 건조 맥문동에 비하여 4배 이상 증폭된 것으로 나타났다. Referring to Table 1, among the opiopogonin components of dried rhizomes, A, B, and C were not detected, and opiopogonin D was 19.07 μg/g, whereas opiopogonin B was 4.78 μg/g in fermented and fermented black malt buds. A small amount was detected, and opiopogonin D was found to be 78.41 μg/g, which was more than 4 times amplified compared to the dry rhizomatous sinus.
실험예 2. 디피피에이치 라디컬(DPPH radical) 소거능 측정Experimental Example 2. Measurement of DPPH radical scavenging ability
1) 실험 방법1) Experiment method
건조 맥문동과 발효증포 맥문동을 각각 물로 추출하여 동결 건조한 시료를 96웰 플레이트(well plate)에 에탄올을 용매로 각 농도별로 조제하여 넣고 0.2 mM 1,1-디페닐l-2-피크릴히드라질(1,1-diphenyl-2-picrylhydrazyl, DPPH) 에탄올 시액을 일정량씩 가하였다. 10초간 진탕한 후 25 oC에서 30분간 방치하고 미크로플레이트 리더기(microplate reader)를 이용하여 517 nm에서 흡광도를 측정하였다. 대조약물은 비타민 C(L-ascorbic acid)를 사용하여 측정하였으며, 각 시료에 대하여 3회 반복하여 측정하였다.Dried and fermented wheatgrass were extracted with water, and freeze-dried samples were prepared for each concentration using ethanol as a solvent in a 96-well plate, and 0.2
2) 실험 결과 2) Experimental results
도 4를 참고하면 디피피에이치 라디컬 소거 효과는 건조 맥문동에 비하여 발효증포 흑맥문동이 2배 이상 강한 소거 효과를 나타내었다. Referring to FIG. 4, the DPH radical scavenging effect was more than twice as strong in the fermentation-vaporised black maltsong compared to the dried malts.
도 5를 참고하면 발효증포 흑맥문동의 분획물 중에서는 메칠렌 클로라이드 분획물과 에틸 아세테이트 분획물이 농도의존적으로 강한 활성을 나타내었으며 에틸 아세테이트 분획물이 조금 더 좋은 성적을 보여주었다. Referring to FIG. 5, among the fractions of fermented and distilled black grapefruit, the methylene chloride fraction and the ethyl acetate fraction showed strong activity in a concentration-dependent manner, and the ethyl acetate fraction showed slightly better results.
실험예 3. 선충 체내의 항산화 효소(SOD, Catalase) 활성 증가 효능Experimental Example 3. Effect of increasing antioxidant enzyme (SOD, Catalase) activity in the body of nematodes
1) 실험 방법1) Experiment method
발효증포 흑맥문동의 물추출물을 성장 단계가 동일한 N2 선충을 각각의 농도별(0μM, 250μM, 500μM)로 조성물이 함유된 플레이트에서 배양하였다. N2 nematodes of the same growth stage as the water extract of fermented steamed black grapefruit were cultured on a plate containing the composition at each concentration (0 μM, 250 μM, 500 μM).
SOD 활성은 성체가 된 후 4일째에 선충을 모아 M9 완충액으로 3회 세척 후 분쇄하여 효소활성 측정에 사용하였다.For SOD activity, nematodes were collected on the 4th day after becoming adults, washed three times with M9 buffer, and then ground and used to measure enzyme activity.
먼저 10mM 인산완충액(phosphate buffer, pH8.0)을 용매로 반응혼합물[1.6mM 크산틴(xanthine)과 0.48mM 니트로블루테트라졸륨(NBT) 0.49mL]을 만든 뒤 시료 10μL와 37℃에서 5분간 사전 배양시켰다.First, a reaction mixture [1.6 mM xanthine and 0.48 mM nitroblue tetrazolium (NBT) 0.49 mL] was prepared using 10 mM phosphate buffer (pH 8.0) as a solvent, and then pre-prepared for 5 minutes at 37 ° C with 10 μL of sample. cultured.
그 후 크산틴옥시다아제(xanthine oxidase) 1mL(0.05U/mL)를 첨가하고 37℃에서 다시 20분 동안 배양한 다음 69mM SDS로 반응을 멈추고 570nm에서 흡광도를 측정하였다.Thereafter, 1 mL (0.05 U/mL) of xanthine oxidase was added and incubated at 37° C. for another 20 minutes, and then the reaction was stopped with 69 mM SDS and absorbance was measured at 570 nm.
Catalase 활성은 Aebi 방법(Method Enzymol. 105: 121-126)을 응용하여 25mM H2O2에 시료 50μL를 3분 동안 반응시키고 240nm에서 흡광도를 측정하였다.Catalase activity was determined by the Aebi method (Method Enzymol. 105: 121-126), followed by reacting 50 μL of the sample with 25 mM H 2 O 2 for 3 minutes and measuring the absorbance at 240 nm.
2) 실험 결과 2) Experimental results
도 6, 7을 참고하면 Xanthine oxidase의 효소반응 과정 중에 생성되는 superoxide anion을 활용하여 SOD의 활성을 측정한 결과 예쁜꼬마선충의 발효증포 흑맥문동 에틸 아세테이트 분획물 투여군은 SOD의 활성을 약 130% 정도 증가시켰다. 한편, Catalase 활성은 128% 증가된 것으로 나타났다. Referring to Figures 6 and 7, the activity of SOD was measured using superoxide anion generated during the enzymatic reaction of Xanthine oxidase. As a result, the group administered with the ethyl acetate fraction of C. made it On the other hand, catalase activity was found to increase by 128%.
실험예 4. 선충 세포 내 활성산소종(ROS) 축적 억제 활성 Experimental Example 4. Reactive oxygen species (ROS) accumulation inhibitory activity in nematode cells
1) 실험 방법1) Experiment method
발효증포 맥문동 물추출물을 성장 단계가 동일한 N2 선충을 각각의 농도별(0μM, 250μM, 500μM)로 조성물이 함유된 플레이트에서 배양하였다.N2 nematodes of the same growth stage of the fermented and fermented extracts of Zephyr vulgaris were cultured on a plate containing the composition at each concentration (0 μM, 250 μM, 500 μM).
선충 세포 내 활성산소종(ROS)은 2’,7’-디클로로디하이드로플로로신 디아세테이트(2’,7’-dichlorodihydro fluorescein diacetate, H2DCF-DA)를 사용하여 측정하였다. 성체가 된 후 4일째 50μM 주글론을 함유한 M9 완충액에 넣고 2시간 노출시킨 뒤 96-well 플레이트에 담긴 50μL M9 완충액에 5마리씩 옮겼다. 마지막으로 25μM H2DCF-DA 50μL를 첨가한 뒤 여기 485nm, 방출 535nm에서 흡광도를 각각 측정하였다.Reactive oxygen species (ROS) in nematode cells were measured using 2',7'-dichlorodihydro fluorescein diacetate (H2DCF-DA). On the 4th day after adulthood, they were placed in M9 buffer containing 50 μM zuglon and exposed for 2 hours, and then transferred to 50 μL M9 buffer in a 96-well plate in groups of 5. Finally, after adding 50 μL of 25 μM H2DCF-DA, the absorbance was measured at 485 nm for excitation and 535 nm for emission.
2) 실험 결과2) Experimental results
도 8을 참고하면 발효증포 흑맥문동 물추출물은 250μM 처리군의 ROS 축적이 6.71%(p<0.05), 500μM 처리군의 ROS 축적이 14.67%(p<0.01)가 감소되어 선충 세포 내 ROS 축적이 상당히 억제됨을 알 수 있었다.Referring to FIG. 8, in the fermentation-enhanced black rhododendron extract, ROS accumulation in the 250 μM treatment group was reduced by 6.71% (p <0.05) and ROS accumulation in the 500 μM treatment group was reduced by 14.67% (p <0.01), indicating that ROS accumulation in nematode cells was reduced. It was found to be significantly suppressed.
실험예 5. 산화적 스트레스 저항성 증가 효능 측정Experimental Example 5. Measurement of oxidative stress resistance increasing efficacy
1) 실험 방법1) Experiment method
발효증포 흑맥문동 물추출물을 성장 단계가 동일한 선충을 각각의 농도별 plate에서 배양하였다(EDZ 250, 500 μg/mL). 산화적 스트레스에 의한 내성은 기존 방법을 약간 변형하여 평가하였으며, 성체가 된 후 7일째에 일시적으로 선충을 1 mM 유글론(juglone)이 함유된 M9 buffer가 담긴 96 well plate에 옮기고 시간 별로 생존율을 확인하였다.Nematodes of the same growth stage were cultured on the plate for each concentration of the fermented and steamed black lentil extract (
2) 실험 결과2) Experimental results
도 9를 참고하면 발효증포 흑맥문동 에틸 아세테이트 분획을 유글론(juglone)으로 산화적 스트레스를 유도한 선충의 생존율에 미치는 영향은 대조군 선충의 최고 생존시간은 25시간이었으나, 에틸 아세테이트 분획 500 μg/mL 농도에서는 생존시간을 30시간으로 증가시켰다. 대조군의 평균 생존시간이 11.5±0.7시간었으나 500μg/mL 농도 처리군은 평균 생존 시간을 16.6±0.9시간으로 44.3% 연장시켰다.Referring to FIG. 9, the effect of fermented vaporized ethyl acetate fraction on the survival rate of nematodes induced by oxidative stress with juglone was that the maximum survival time of the control nematode was 25 hours, but the
실험예 6. 형질전환 선충 내 SOD-3::GFP 형광 측정Experimental Example 6. Measurement of SOD-3::GFP fluorescence in transgenic nematodes
1) 실험 방법1) Experiment method
발효증포 흑맥문동 물추출물을 형질 전환된 선충으로 SOD-3::GFP를 포함한 CF1553을 시료를 농도별로 제조된 배지에 넣어 배양하였다. 성체가 된 후 4일째에 사용하였으며, 선충은 sodium azide(4%)로 마취시켰고 GFP 발현은 형광 실체 현미경(Olympus, Japan)으로 관찰하였다. 발현강도를 정량, 분석하기 위해 현미경을 이용한 사진 촬영과 ImageJ 소프트웨어를 사용하여 분석하였으며, 모든 실험은 3회 반복하였다.CF1553 samples containing SOD-3::GFP as nematodes transformed from the fermented and steamed black rhombus extract were cultured in a medium prepared for each concentration. It was used on the 4th day after becoming an adult. The nematodes were anesthetized with sodium azide (4%), and GFP expression was observed under a fluorescence stereomicroscope (Olympus, Japan). In order to quantify and analyze the expression intensity, photographs were taken using a microscope and analyzed using ImageJ software, and all experiments were repeated three times.
2) 실험 결과2) Experimental results
도 10을 참고하면 발효증포 흑맥문동 에틸아세테이트 분획의 선충 내에서 산화적 스트레스에 저항하기 위한 단백질의 증가 여부를 확인하기 위해 SOD-3를 포함한 형질전환 선충 CF1553을 사용하여 실험한 결과, CF1553 형질전환 선충에 발효증포 흑맥문동 에틸 아세테이트 분획 500 μg/mL 처리군이 처리되지 않은 선충에 비해 11.7% 높은 SOD-3::GFP 발현율을 나타내었다. Referring to FIG. 10, in order to determine whether the protein for resisting oxidative stress in the nematodes of the fermented and distilled ethyl acetate fraction was tested using the transformed nematode CF1553 containing SOD-3, CF1553 transformation In the nematodes treated with 500 μg/mL of fermented nematode ethyl acetate fraction, the expression rate of SOD-3::GFP was 11.7% higher than that of the untreated nematodes.
이상의 설명에서는 본 발명의 다양한 실시 예들을 제시하여 설명하였으나 본 발명이 반드시 이에 한정되는 것은 아니며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 여러 가지 치환, 변형 및 변경이 가능함을 쉽게 알 수 있을 것이다. In the above description, various embodiments of the present invention have been presented and described, but the present invention is not necessarily limited thereto. It will be readily apparent that branch substitutions, modifications and alterations are possible.
Claims (6)
(2) 전처리된 상기 맥문동에 천연과일 당침발효 숙성액을 가하여 발효시키는 1차 발효 단계 ;
(3) 상기 1차 발효 단계를 거친 상기 맥문동에 다시 상기 천연과일 당침발효 숙성액을 분사하여 발효시키는 2차 발효 단계;
(4) 상기 2차 발효과정을 거친 맥문동을 일정 온도에서 숙성시키는 단계 ;
(5) 상기 숙성단계를 거친 맥문동을 증숙기에 넣고 스팀을 통과시켜 증숙시키는 단계 ;
(6) 상기 증숙단계를 거친 맥문동을 건조시키는 단계 ; 를 포함하는 원형 발효 증포 흑맥문동의 제조방법.(1) a pretreatment step of putting the wheatgrass in a washing tank, washing it with hot water, and drying it in a hot air dryer;
(2) a first fermentation step of fermenting by adding a natural fruit sweetener fermented liquid to the pre-treated Maekmundong;
(3) a secondary fermentation step of fermenting by injecting the natural fruit sugar syrup fermentation liquid back into the macmundong that has gone through the primary fermentation step;
(4) ripening the maekmundong that has undergone the secondary fermentation process at a constant temperature;
(5) Putting the ripening step into a steamer and steaming it through steam;
(6) drying the maekmundong that has undergone the steaming step; A method for producing circular fermented steamed black maltose comprising a.
무화과 열매, 배, 키위, 매실 및 개복숭아 중 어느 하나의 과일에 설탕을 가한 후 발효시켜 제조된 과일 효소액인 것을 특징으로 하는 원형 발효 증포 흑맥문동의 제조방법. The method of claim 1, wherein the natural fruit syrup fermented liquid is
A method for producing circular fermented steamed black maltose, characterized in that it is a fruit enzyme liquid prepared by adding sugar to any one of fig fruit, pear, kiwi, plum and peach and then fermenting it.
(a) 상기 천연과일 당침발효 숙성액 중 어느 하나를 상기 맥문동에 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하는 단계 ;
(b) 상기 천연과일 당침발효 숙성액 중 나머지 어느 하나를 상기 (a) 단계를 거친 맥문동에 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하는 단계 ; 및
상기 천연과일 당침발효 숙성액 중 마지막 숙성액까지 순차적으로 (b) 단계를 거친 맥문동에 가하거나 분사하여 상기 (2) 1차 발효 단계, (3) 2차 발효 단계 및 (4) 숙성단계를 진행하는 단계를 포함하는 것을 특징으로 하는 원형 발효 증포 흑맥문동의 제조방법. The method of claim 2, wherein the (2) primary fermentation step to (4) aging step
(a) performing the (2) primary fermentation step, (3) secondary fermentation step, and (4) ripening step by adding or spraying any one of the natural fruit sugar needle fermentation liquid to the maltberry;
(b) Adding or spraying the remaining one of the natural fruit sugar needle fermentation liquid to the wheatgrass that has gone through the step (a), the (2) primary fermentation step, (3) secondary fermentation step, and (4) aging step to proceed; and
Among the natural fruit sugar needle fermented liquids, up to the last matured liquid is sequentially added or sprayed to Maekmundong that has undergone step (b) to proceed with the (2) 1st fermentation step, (3) 2nd fermentation step and (4) ripening step A method for producing circular fermented vaporized black maltose, characterized in that it comprises the step of.
상기 추출액을 여과하고 여액을 감압농축기에 넣고 농축시키는 단계를 포함하는 발효증포 흑맥문동 복합 액상제제의 제조방법.
Heat-extracting by adding water to the circular fermented and steamed black maltose, black bellflower concentrate, and black ginseng concentrate prepared according to any one of claims 1 to 5;
A method for producing a fermentation-vaporized black maltose complex liquid preparation comprising the step of filtering the extract and concentrating the filtrate in a vacuum concentrator.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210113605A KR20230031411A (en) | 2021-08-27 | 2021-08-27 | Method of manufacturing black maekmundong and liquid preparations enhanced steroidal saponin contents and antioxidant activity by fermentation and nine steam and dry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210113605A KR20230031411A (en) | 2021-08-27 | 2021-08-27 | Method of manufacturing black maekmundong and liquid preparations enhanced steroidal saponin contents and antioxidant activity by fermentation and nine steam and dry |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230031411A true KR20230031411A (en) | 2023-03-07 |
Family
ID=85513259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210113605A KR20230031411A (en) | 2021-08-27 | 2021-08-27 | Method of manufacturing black maekmundong and liquid preparations enhanced steroidal saponin contents and antioxidant activity by fermentation and nine steam and dry |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230031411A (en) |
-
2021
- 2021-08-27 KR KR1020210113605A patent/KR20230031411A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101041403B1 (en) | Cosmetic Composition for Anti-oxidation and Whitening | |
KR101050821B1 (en) | Fermented black-red ginseng and the method of preparing it and fermented bellflower and fermented ginger | |
KR102304498B1 (en) | Composition for anti-transmissible gastroenteritis virus (tgev) and pharmaceutical composition including the same | |
US20090098223A1 (en) | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea | |
KR100844454B1 (en) | Beverage of ginseng fruit and manufacturing method thereof | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
CN110810693A (en) | A beverage composition containing Ampelopsis grossedentata and its preparation method | |
KR101794006B1 (en) | Anti inflammatory comprising plant extract | |
KR20130093371A (en) | Novel preparation method of mulberry leaf extract for anti-hypertensive, anti-diabetic, and anti-aging and the product of the same | |
CN113893310A (en) | Mountain plant fermentation composition and preparation method and application thereof | |
KR101335939B1 (en) | Method for producing fermented godeulbbaaegi pickle and fermented godeulbbaaegi pickle by the same method | |
KR20160059137A (en) | MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR101359078B1 (en) | Method of processing roots of wild ginseng | |
KR20180058144A (en) | Sea buckthorn beverage and preparation method thereof | |
KR20150105029A (en) | Morus Alba Leaf, Ramulus Mori, Mori radicis Cortex, Mulberry and Phellinus linteus mixed extract and manufacturing method thereof | |
KR100852138B1 (en) | Manufacturing method for extract of fruit and ginseng spray | |
KR20230031411A (en) | Method of manufacturing black maekmundong and liquid preparations enhanced steroidal saponin contents and antioxidant activity by fermentation and nine steam and dry | |
CN114288331A (en) | Method for simultaneously extracting volatile oil from effective parts of total flavonoids and total saponins of Chinese medicinal fenugreek, extract and application thereof | |
KR20130085576A (en) | Preparation method for fermented ginseng berry extract | |
KR101071154B1 (en) | Stress relieving composition comprising zizyphus jujuba extract | |
CN107509838A (en) | A kind of preparation method of fermented black rice tea | |
KR20210050103A (en) | Immune enhancing liquid composition having increased ginsenosides Rb1, Rg1 and Rg3 and preparation method thereof | |
KR102627124B1 (en) | Manufacturing method of Jelly Stick using Wood Cultivated Ginseng | |
KR20200132439A (en) | Method for Manufacturing Fermented Ginseng Tablet | |
KR102504487B1 (en) | Glechoma hederacea var extract with skin barrier protection function and its manufacturing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |